Ding Ma
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 10
-
- Breast Cancer Treatment Studies 16
- Cancer Genomics and Diagnostics 15
- Cancer, Hypoxia, and Metabolism 9
- Co-authors
- Yi‐Zhou Jiang (19 shared papers)Da‐Qiang Li (7 shared papers)Xi Jin (10 shared papers)Zhi‐Ming Shao (8 shared papers)Yi Xiao (10 shared papers)Xin Hu (9 shared papers)Gang Chen (17 shared papers)Zhiqiang Han (1 shared paper)
- Journals
- Oncology Reports (9 papers)Cancer Research (8 papers)Oncotarget (7 papers)Scientific Reports (7 papers)Advanced Science (4 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Ding Ma
200 papers receiving 6.0k citations
Ding Ma's Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 1.6k
- Oncology 1.4k
- Molecular Biology 2.5k
- Reproductive Medicine 267
- Immunology 685
Countries citing papers authored by Ding Ma
This map shows the geographic impact of Ding Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Ma more than expected).
Fields of papers citing papers by Ding Ma
This network shows the impact of papers produced by Ding Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Ma. The network helps show where Ding Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy Hit paper breakdown → | 2022 | 437 |
| 2 | Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends Hit paper breakdown → | 2023 | 373 |
| 3 | Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets Hit paper breakdown → | 2020 | 316 |
| 4 | The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Hit paper breakdown → | 2022 | 292 |
| 5 | 2019 | 270 | |
| 6 | 2012 | 268 | |
| 7 | 2020 | 206 | |
| 8 | 2013 | 144 | |
| 9 | 2019 | 141 | |
| 10 | 2020 | 123 | |
| 11 | 2023 | 103 | |
| 12 | 2015 | 102 | |
| 13 | 2013 | 87 | |
| 14 | 2021 | 86 | |
| 15 | 2021 | 86 | |
| 16 | 2013 | 81 | |
| 17 | 2022 | 75 | |
| 18 | 2014 | 71 | |
| 19 | 2018 | 65 | |
| 20 | 2009 | 57 |
About Ding Ma
Ding Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 208 papers that have together received 6.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Cancer Genomics and Diagnostics (15 papers), Cervical Cancer and HPV Research (13 papers), RNA modifications and cancer (11 papers), Ovarian cancer diagnosis and treatment (10 papers), Epigenetics and DNA Methylation (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.4k citations), Molecular Biology (2.5k citations), Reproductive Medicine (267 citations) and Immunology (685 citations). Ding Ma has collaborated with scholars based in China, United States and India. Frequent co-authors include Yi‐Zhou Jiang, Da‐Qiang Li, Xi Jin, Zhi‐Ming Shao, Yi Xiao, Xin Hu, Gang Chen, Zhiqiang Han, Zhenya Hong and Liangliang Wang. Their work appears in journals such as Oncology Reports, Cancer Research, Oncotarget, Scientific Reports and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.